| 2014-04 |
Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones |
European Journal of Medicinal Chemistry. 2014 Apr 22;77(2):306-314. |
 |
| 2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib |
Cell Death and Disease. 2014 Apr;5:Article number e1162. |
|
| 2014-03 |
LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling |
Oncogene. 2014 Mar;33(11):1375-1384. |
|
| 2014-02 |
A novel cancer therapeutic using thrombospondin 1 in dendritic cells |
Molecular Therapy. 2014 Feb;22(2):292-302. |
|
| 2014-01-10 |
Reciprocal regulation of MicroRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells |
Molecular Cancer. 2014 Jan 10;13:Article number 6. |
|
| 2013-12 |
Autophagy induced by cathepsin S inhibition induces early ROS production, oxidative DNA damage, and cell death via xanthine oxidase |
Free Radical Biology and Medicine. 2013 Dec;65:1473-1486. |
|
| 2013-12 |
Mechanical regulation of cancer cell apoptosis and autophagy: Roles of bone morphogenetic protein receptor, Smad1/5, and p38 MAPK |
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2013 Dec;1833(12):3124-3133. |
|
| 2013-10-16 |
Survivin - biology and potential as a therapeutic target in oncology |
Oncotargets and Therapy. 2013 Oct 16;6:1453-1462. |
|
| 2013-10 |
Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification |
Biochemical Pharmacology. 2013 Oct;86(7):872-887. |
|
| 2013-10 |
Investigating the association between oral hygiene and head and neck cancer |
Oral Oncology. 2013 Oct;49(10):1010-1017. |
|
| 2013-09 |
MPT0B169, a new tubulin inhibitor, inhibits cell growth and induces G2/M Arrest in nonresistant and paclitaxel-resistant cancer cells |
Pharmacology. 2013 Sep;92(1-2):90-98. |
|
| 2013-09 |
MPT0B098, a novel microtubule inhibitor that destabilizes the hypoxia-inducible factor-1α mrna through decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR [Erratum: Molecular Cancer Therapeutics. 2013 Jul;12(7):1202-1212.] |
Molecular Cancer Therapeutics. 2013 Sep;12(9):1919. |
|
| 2013-09 |
Furanylazaindoles: Potent anticancer agents in vitro and in vivo |
Journal of Medicinal Chemistry. 2013 Sep;56(20):8008-8018. |
|
| 2013-07-15 |
Microtubule-associated histone deacetylase 6 supports the calcium store sensor STIM1 in mediating malignant cell behaviors |
Cancer Research. 2013 Jul 15;73(14):4500-4509. |
|
| 2013-07 |
Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma |
Journal of Pathology. 2013 Jul;230(3):298-309. |
|
| 2013-07 |
MPT0B098, a novel microtubule inhibitor that destabilizes the hypoxia-inducible factor-1 alpha mRNA through decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR |
Molecular Cancer Therapeutics. 2013 Jul;12(7):1202-1212. |
|
| 2013-06-27 |
Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance |
Journal of Biomedical Science. 2013 Jun 27;20(1):Article number 43. |
|
| 2013-06-13 |
Cholestane-3beta, 5alpha, 6beta-triol suppresses proliferation, migration, and invasion of human prostate cancer cells |
PLoS ONE. 2013 Jun 13;8(6):Article number e65734. |
|
| 2013-05 |
Activation of PPAR-alpha induces cell cycle arrest and inhibits transforming growth factor-beta1 induction of smooth muscle cell phenotype in 10T1/2 mesenchymal cells |
Cellular Signalling. 2013 May;25(5):1252-1263. |
|
| 2013-04-24 |
Caffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signaling |
International Journal of Molecular Sciences. 2013 Apr 24;14(5):8801-8817. |
|
| 2013-03-12 |
A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway |
PLoS ONE. 2013 Mar 12;8(3):Article number e58953. |
|
| 2013-02-01 |
Allergies and risk of head and neck cancer: An original study plus meta-analysis |
PLoS ONE. 2013 Feb 1;8(2):Article number e55138. |
|
| 2013-01 |
Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma |
Alimentary Pharmacology and Therapeutics. 2013 Jan;37(1):62-73. |
|
| 2012-12 |
Arginine deprivation as a new treatment strategy for head and neck cancer |
Oral Oncology. 2012 Dec;48(12):1227-1235. |
|
| 2012-12 |
Application of Suzuki arylation, Sonogashira ethynylation and Rosenmund-von Braun cyanation in the exploration of substitution effects on the anticancer activity of 2-aroylquinolines |
Organic and Biomolecular Chemistry. 2012 Dec;10(48):9593-9600. |
|
